Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic testing in interstitial lung disease: An international survey.
Terwiel M, Borie R, Crestani B, Galvin L, Bonella F, Fabre A, Froidure A, Griese M, Grutters JC, Johannson K, Kannengiesser C, Kawano-Dourado L, Molina-Molina M, Prasse A, Renzoni EA, van der Smagt J, Poletti V, Antoniou K, van Moorsel CHM. Terwiel M, et al. Among authors: galvin l. Respirology. 2022 Sep;27(9):747-757. doi: 10.1111/resp.14303. Epub 2022 Jun 2. Respirology. 2022. PMID: 35652243
The Ariane-IPF ERS Clinical Research Collaboration: seeking collaboration through launch of a federation of European registries on idiopathic pulmonary fibrosis.
Cottin V, Annesi-Maesano I, Günther A, Galvin L, Kreuter M, Powell P, Prasse A, Reynolds G, Richeldi L, Spagnolo P, Valenzuela C, Wijsenbeek M, Wuyts WA, Crestani B; Ariane-IPF Clinical Research Collaboration consortium. Cottin V, et al. Among authors: galvin l. Eur Respir J. 2019 May 23;53(5):1900539. doi: 10.1183/13993003.00539-2019. Print 2019 May. Eur Respir J. 2019. PMID: 31123022 Free article. No abstract available.
Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide survey.
Moor CC, Wijsenbeek MS, Balestro E, Biondini D, Bondue B, Cottin V, Flewett R, Galvin L, Jones S, Molina-Molina M, Planas-Cerezales L, Prasse A, Prosch H, Russell AM, Viegas M, Wanke G, Wuyts W, Kreuter M, Bonella F. Moor CC, et al. Among authors: galvin l. ERJ Open Res. 2019 Oct 21;5(4):00124-2019. doi: 10.1183/23120541.00124-2019. eCollection 2019 Oct. ERJ Open Res. 2019. PMID: 31649949 Free PMC article.
Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures.
Wijsenbeek M, Molina-Molina M, Chassany O, Fox J, Galvin L, Geissler K, Hammitt KM, Kreuter M, Moua T, O'Brien EC, Slagle AF, Krasnow A, Reaney M, Baldwin M, Male N, Rohr KB, Swigris J, Antoniou K. Wijsenbeek M, et al. Among authors: galvin l. ERJ Open Res. 2022 May 3;8(2):00681-2021. doi: 10.1183/23120541.00681-2021. eCollection 2022 Apr. ERJ Open Res. 2022. PMID: 35509443 Free PMC article.
Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement.
Cottin V, Selman M, Inoue Y, Wong AW, Corte TJ, Flaherty KR, Han MK, Jacob J, Johannson KA, Kitaichi M, Lee JS, Agusti A, Antoniou KM, Bianchi P, Caro F, Florenzano M, Galvin L, Iwasawa T, Martinez FJ, Morgan RL, Myers JL, Nicholson AG, Occhipinti M, Poletti V, Salisbury ML, Sin DD, Sverzellati N, Tonia T, Valenzuela C, Ryerson CJ, Wells AU. Cottin V, et al. Among authors: galvin l. Am J Respir Crit Care Med. 2022 Aug 15;206(4):e7-e41. doi: 10.1164/rccm.202206-1041ST. Am J Respir Crit Care Med. 2022. PMID: 35969190 Free PMC article.
European Respiratory Society statement on familial pulmonary fibrosis.
Borie R, Kannengiesser C, Antoniou K, Bonella F, Crestani B, Fabre A, Froidure A, Galvin L, Griese M, Grutters JC, Molina-Molina M, Poletti V, Prasse A, Renzoni E, van der Smagt J, van Moorsel CHM. Borie R, et al. Among authors: galvin l. Eur Respir J. 2023 Mar 16;61(3):2201383. doi: 10.1183/13993003.01383-2022. Print 2023 Mar. Eur Respir J. 2023. PMID: 36549714 Review.
I-PreFer Study: A Discrete Choice Experiment to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Pharmacological Treatment Options.
Hollmen M, Wijsenbeek M, Bromilow T, Smith AB, Mealing S, Lewis D, Galvin L, Jones S, Asijee G, Soulard S, Froidure A. Hollmen M, et al. Among authors: galvin l. Patient Prefer Adherence. 2023 Aug 4;17:1895-1906. doi: 10.2147/PPA.S409767. eCollection 2023. Patient Prefer Adherence. 2023. PMID: 37560147 Free PMC article.
59 results